0

Ibotenic Acid and Thioibotenic Acid: A Remarkable Difference in Activity at Group III Metabotropic Glutamate Receptors

Mette B Hermit, Jeremy R Greenwood, Birgitte Nielsen, Lennart Bunch, Charlotte G Jørgensen, Henrik T Vestergaard, Tine B Stensbøl, Connie Sanchez, Povl Krogsgaard-Larsen, Ulf Madsen, Hans Bräuner-Osborne

Eur J Pharmacol. 2004 Feb 23;486(3):241-50.

PMID: 14985045

Abstract:

In this study, we have determined and compared the pharmacological profiles of ibotenic acid and its isothiazole analogue thioibotenic acid at native rat ionotropic glutamate (iGlu) receptors and at recombinant rat metabotropic glutamate (mGlu) receptors expressed in mammalian cell lines. Thioibotenic acid has a distinct pharmacological profile at group III mGlu receptors compared with the closely structurally related ibotenic acid; the former is a potent (low microm) agonist, whereas the latter is inactive. By comparing the conformational energy profiles of ibotenic and thioibotenic acid with the conformations preferred by the ligands upon docking to mGlu1 and models of the other mGlu subtypes, we propose that unlike other subtypes, group III mGlu receptor binding sites require a ligand conformation at an energy level which is prohibitively expensive for ibotenic acid, but not for thioibotenic acid. These studies demonstrate how subtle differences in chemical structures can result in profound differences in pharmacological activity.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP2552558 Ibotenic acid Ibotenic acid 2552-55-8 Price
qrcode